» Articles » PMID: 35898467

Undercarboxylated Osteocalcin and Its Associations With Bone Mineral Density, Bone Turnover Markers, and Prevalence of Osteopenia and Osteoporosis in Chinese Population: A Cross-Sectional Study

Overview
Specialty Endocrinology
Date 2022 Jul 28
PMID 35898467
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Undercarboxylated osteocalcin (ucOC) is one form of osteocalcin lacking full carboxylation, which plays an important role in bone homeostasis, glucose homeostasis, and energy metabolism. Our aim is to obtain the profile of serum ucOC level according to gender and age and explore its associations with bone mineral density (BMD), bone turnover markers (BTMs), and prevalence of osteopenia and osteoporosis in the Chinese population.

Methods: This is a cross-sectional study with 900 subjects, composed of 431 men and 469 women. Clinical information was collected, and BMD values of the lumbar spine (L1-4), left femoral neck, and total hip were scanned. Biochemical markers including hepatic and renal function, serum calcium, serum phosphorus, procollagen type 1 N-propeptide (P1NP) β-CrossLaps of type I collagen-containing cross-linked C-telopeptide (β-CTX) intact parathyroid hormone (PTH), 25-hydroxyvitamin D (25OHD), and ucOC were measured.

Results: We found that the median ucOC level was higher in men than women [men, 2.6 ng/ml; women, 1.6 ng/ml; < 0.001]. The profile according to age showed that ucOC levels were the lowest at the age of 40-49 years in both men [2.55 ng/ml (95% CI = 1.96-3.13 ng/ml)] and women [1.57 ng/ml (95% CI = 1.12-2.03 ng/ml)]; in patients younger than 49 years, they decreased with age; then over 50 years, they quickly increased. Furthermore, we found that a higher ucOC level was correlated with lower BMD values at the lumbar spine (men, r = -0.128, = 0.013; women, r = -0.321, < 0.001), femoral neck (men, r = -0.095, = 0.062; women, r = -0.260, < 0.001), and total hip (men, r = -0.123, = 0.015; women, r = -0.209, < 0.001) and higher P1NP (men, r = 0.307, < 0.001; women, r = 0.239, < 0.001) and β-CTX (men, r = 0.169, = 0.001; women, r = 0.354, < 0.001) levels in both men and women. Furthermore, we also showed that a 1 - SD increase in ucOC was associated with an odds ratio (OR) of 1.63 and 1.70 for having osteopenia or osteoporosis in men and women, respectively (men, 95% CI = 1.25-2.13, = 0.004; women, 95% CI = 1.19-2.42, = 0.004).

Conclusions: We first revealed the profile of serum ucOC levels according to gender and age in the Chinese population and demonstrated the associations of ucOC with BMD and BTMs and the risk of prevalent osteopenia or osteoporosis. Our findings provide a clue to elucidate the function of ucOC in bone metabolism.

Citing Articles

Unraveling the impact of blood RANKL and OPG levels on Alzheimer's disease: Independent of bone mineral density and inflammation.

Guo X, Shi W, Lu J, Tang P, Li R Alzheimers Dement (N Y). 2025; 11(1):e70044.

PMID: 39839077 PMC: 11746068. DOI: 10.1002/trc2.70044.


Osteoporosis in men-East and West: Can the twain meet? A perspective from Asia.

Sng G, Reginster J, Alokail M, Chandran M Osteoporos Sarcopenia. 2025; 10(4):131-144.

PMID: 39835326 PMC: 11742312. DOI: 10.1016/j.afos.2024.11.001.


The Protective Role of Vitamin K in Aging and Age-Related Diseases.

Kazmierczak-Baranska J, Karwowski B Nutrients. 2025; 16(24.

PMID: 39770962 PMC: 11676630. DOI: 10.3390/nu16244341.


The Role of Bone-Derived Osteocalcin in Testicular Steroidogenesis: Contributing Factor to Male Fertility.

Taib I, Jayusman P Diseases. 2024; 12(12.

PMID: 39727665 PMC: 11727589. DOI: 10.3390/diseases12120335.


The Role of Osteocalcin in Patients with Osteoporosis: A Systematic Review.

Mohammadi S, Saniee N, Mousaviasl S, Radmanesh E, Doustimotlagh A Iran J Public Health. 2024; 53(11):2432-2439.

PMID: 39619893 PMC: 11607154. DOI: 10.18502/ijph.v53i11.16945.


References
1.
Gundberg C, Nieman S, Abrams S, Rosen H . Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab. 1998; 83(9):3258-66. DOI: 10.1210/jcem.83.9.5126. View

2.
Ito K, Ookawara S, Hibino Y, Imai S, Fueki M, Bandai Y . Skeletal Muscle Mass Index Is Positively Associated With Bone Mineral Density in Hemodialysis Patients. Front Med (Lausanne). 2020; 7:187. PMC: 7242614. DOI: 10.3389/fmed.2020.00187. View

3.
Delmas P . Biochemical markers of bone turnover for the clinical investigation of osteoporosis. Osteoporos Int. 1993; 3 Suppl 1:81-6. DOI: 10.1007/BF01621873. View

4.
Delaisse J, Andersen T, Kristensen H, Jensen P, Andreasen C, Soe K . Re-thinking the bone remodeling cycle mechanism and the origin of bone loss. Bone. 2020; 141:115628. DOI: 10.1016/j.bone.2020.115628. View

5.
Greenblatt M, Tsai J, Wein M . Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease. Clin Chem. 2016; 63(2):464-474. PMC: 5549920. DOI: 10.1373/clinchem.2016.259085. View